• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24620
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Reocclusion (1985); Claudication (2550)
Event Date 09/12/2019
Event Type  Injury  
Event Description
It was reported that intermittent claudication occurred.The subject was enrolled in the imperial clinical study on (b)(6) 2016 and the index procedure was performed on the same day.The target lesion was located in the left distal superficial femoral artery (sfa) with 95% stenosis.The target lesion was 120 mm long with a proximal reference vessel diameter of 4 mm and distal vessel diameter of 4.5 mm and was classified as tasc ii b lesion.The target lesion was treated with pre-dilation and placement of a 6mm x 150mm eluvia study stent.Residual stenosis was 0% following post-dilation.On (b)(6) 2019, 1266 days post-index procedure, the subject had a complaint of intermittent claudication of the left lower extremity.On (b)(6) 2019, 1293 days post-index procedure, the subject was admitted to the hospital with a history of recurrent stenosis of the proximal end of previously constructed left femoropopliteal bypass.Angiogram was performed on the same day which revealed high grade stenosis at the proximal and beyond the proximal anastomosis of previously constructed femoropopliteal bypass, two vessel run-off in the foot in the form of peroneal artery and anterior tibial artery.The 100% stenosis was located in the left proximal, mid and distal sfa to the popliteal artery.Pre-dilation was performed using two balloons.Subsequent angiogram revealed, some elastic recoil with a filing defect noted in bypass graft distal to the area of angioplasty.A non-bsc stent was advanced to the area and deployed to trap the clot, which travelled further distally and occluded the peroneal artery.A non-bsc catheter was advanced into the peroneal artery and suction mechanical thrombectomy was performed to retrieve the clot.Subsequent angiogram revealed a spasm in the peroneal artery which was treated with a balloon with complete resolution.The proximal area noted to again have some recoil which was treated with the placement of a stent.The residual stenosis was noted 0%.On (b)(6) 2019, the event was considered to be resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key9284518
MDR Text Key165251509
Report Number2134265-2019-13407
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 11/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2017
Device Model Number24620
Device Catalogue Number24620
Device Lot Number0018349132
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/16/2019
Initial Date FDA Received11/06/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/28/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
-
-